Immunotherapy: Impact Factor, Indexing, Publication Time & Fees
The Immunotherapy is reputed journal publishes research related to Immunology (Q3); Immunology and Allergy (Q3); Oncology (Q3). The ISSN of the journal is .
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
Immunotherapy: Details
| Journal Title | Immunotherapy |
|---|
| Publisher | Taylor and Francis Ltd. |
|---|
| Publication Country | United Kingdom |
|---|
| ISSN | 1750743X, 17507448 |
|---|
| Publication Area | Immunology and Microbiology; Medicine |
|---|
| Publication Language | ENG |
|---|
| Review Process | |
|---|
| Scopus Indexed | Yes |
|---|
Immunotherapy Impact Factor
The Impact Factor of Immunotherapy in 2026 is 2.3.
Journal Quartile
The Immunotherapy is ranked in Q3.
Indexing
The Immunotherapy is indexed in: Web of Science.
Similiar journals to publish
ISSN: Publisher: BMJ Publishing Group
Journal Scope: Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)
ISSN: Publisher: Springer Science and Business Media Deutschland GmbH
Journal Scope: Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)
ISSN: Publisher: Oxford University Press
Journal Scope: Immunology (Q1)
ISSN: Publisher: Innovative Healthcare Institute
Journal Scope: Immunology (Q1); Immunology and Allergy (Q1); Oncology (Q1); Cancer Research (Q2)
ISSN: Publisher: Lippincott Williams and Wilkins
Journal Scope: Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2)
ISSN: Publisher: SAGE Publications Ltd
Journal Scope: Drug Discovery (Q2); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2); Pharmacology (medical) (Q2)